HALO
#827
Halozyme Therapeutics, Inc. - Common Stock
105.3 5 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.47%
Variación mensual
+28.88%
Variación en los últimos 6 meses
+54.19%
Cambio anual
+57.71%
Cierres anteriores
106.9 2
Open
105.3 5
Mínimo
105.3 5
Máximo
105.3 5
Volumen
139
Financials
- Market Capitalization 11.96 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
26.29
Relación precio/flujo de caja
5.97
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 810 |  CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | +1.68% | +55.21% | 12.31 B USD | ||
| 824 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.91 USD | -4.15% | -2.14% | -3.08% | +117.16% | 11.99 B USD | ||
| 852 |  TECH Bio-Techne Corp - Common Stock | 72.35 USD | -0.17% | +0.11% | +0.47% | +33.56% | 11.35 B USD | ||
| 870 |  SMMT Summit Therapeutics Inc. - Common Stock | 13.73 USD | -4.19% | +5.05% | +7.35% | -30.87% | 10.95 B USD |